US EditionOkami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
The $45 million investment will support Okami Medical's commercial growth, clinical program advancement, and device innovation to improve vascular disease patient outcomes.
- Nov. 19, 2025, Okami Medical, Inc., Aliso Viejo, Calif., closed an oversubscribed $45M financing led by Gilde Healthcare with participation from Vensana Capital and U.S. Venture Partners.
- To expand patient access, the financing will fund commercial expansion and clinical programs, supporting Okami Medical, Inc.'s mission to improve outcomes for patients with vascular disease.
- Drew Hykes was named President and CEO, with Bill Hoffman appointed Chairman, while Geoff Pardo and Susana Amorim of Gilde Healthcare joined Okami Medical's Board of Directors.
- Geoff Pardo of Gilde Healthcare said, `We have followed Okami for years and have been impressed by the strength of its technology and the scale of its market opportunity`, adding Gilde is pleased to partner with Drew Hykes following prior success at Inari.
- Gilde Healthcare manages 2.6 billion across its Venture&Growth and Private Equity strategies, with Vensana Capital, which has approximately $1 billion under management, participating in the round, as Geoff Pardo said, `We have followed Okami for years and have been impressed by the strength of its technology and the scale of its market opportunity`.
17 Articles
17 Articles
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
ALISO VIEJO, Calif., Nov. 19, 2025 /PRNewswire/ -- Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors…
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
ALISO VIEJO, Calif., Nov. 19, 2025 /PRNewswire/ -- Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors…
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
ALISO VIEJO, Calif., Nov. 19, 2025 /PRNewswire/ -- Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors…
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
ALISO VIEJO, Calif., Nov. 19, 2025 /PRNewswire/ -- Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors…
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
ALISO VIEJO, Calif., Nov. 19, 2025 /PRNewswire/ -- Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors…
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
ALISO VIEJO, Calif., Nov. 19, 2025 /PRNewswire/ -- Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors…
Coverage Details
Bias Distribution
- 78% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
